We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$668M
Cap. Flow
+$51.1M
Cap. Flow %
1.72%
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$120M
2
LLY icon
Eli Lilly
LLY
+$117M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$70.3M
4
AMZN icon
Amazon
AMZN
+$16.6M
5
PLTR icon
Palantir
PLTR
+$16.1M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$239M
2
RNAM
Avidity Biosciences
RNAM
+$210M
3
AAPL icon
Apple
AAPL
+$183M
4
AMD icon
Advanced Micro Devices
AMD
+$98.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$91.7M

Sector Composition

Rank Sector Weight
1 Technology 35.38%
2 Financials 18.17%
3 Healthcare 16.24%
4 Consumer Discretionary 10.31%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLAO
176
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
$541K 0.02%
46,605
+449
+1% +$5.18K
RFAI
177
RF Acquisition Corp II
RFAI
$92.4M
$541K 0.02%
+53,180
New +$537K
PARA
178
DELISTED
Paramount Global Class B
PARA
$531K 0.02%
+50,000
New +$544K
LAB icon
179
Standard BioTools
LAB
$326M
$530K 0.02%
274,420
– –
NKE icon
180
PUT
Nike
NKE
$61.9B
$515K 0.02%
209,800
-790,200
-79% -$62M
GCTS.WS
181
GCT Semiconductor Holding Warrants
GCTS.WS
$15.4M
$487K 0.02%
3,743,950
+1,335,247
+55% +$196K
BBOT
182
BridgeBio Oncology
BBOT
$707M
$471K 0.02%
45,048
-5,463
-11% -$56.5K
DNLI icon
183
Denali Therapeutics
DNLI
$3.67B
$460K 0.02%
+15,800
New +$392K
SPY icon
184
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$443K 0.01%
125,000
+55,000
+79% +$30.4M
JSPRW icon
185
Japer Therapeutics Warrants
JSPRW
$183K
$441K 0.01%
2,206,248
+35,499
+2% +$7.48K
ABLLW
186
DELISTED
Abacus Life Warrant
ABLLW
$440K 0.01%
258,992
+8,992
+4% +$10.6K
UCFI
187
CN Healthy Food Tech Group
UCFI
$440K 0.01%
43,168
-79,100
-65% -$801K
MGNI icon
188
Magnite
MGNI
$2.65B
$427K 0.01%
+30,800
New +$420K
SKWD icon
189
Skyward Specialty Insurance
SKWD
$2.45B
$407K 0.01%
+10,000
New +$387K
KDKRW
190
Kodiak AI Warrants
KDKRW
$390K 0.01%
2,435,496
+1,580,657
+185% +$205K
HYAC.WS
191
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
$384K 0.01%
2,397,941
+4,654
+0.2% +$854
CTLT
192
DELISTED
CATALENT, INC.
CTLT
$381K 0.01%
+6,288
New +$372K
CLDX icon
193
Celldex Therapeutics
CLDX
$2.77B
$364K 0.01%
+10,700
New +$408K
AFJKR
194
Aimei Health Technology Co Right
AFJKR
$358K 0.01%
1,556,466
+393,400
+34% +$96.8K
TPR icon
195
Tapestry
TPR
$28.8B
$352K 0.01%
+7,500
New +$309K
HOOD icon
196
CALL
Robinhood
HOOD
$85.2B
$348K 0.01%
70,000
– –
DECA
197
DELISTED
Denali Capital Acquisition Corp. Class A Ordinary Shares
DECA
$348K 0.01%
+30,000
New +$344K
CXAIW icon
198
CXApp Inc Warrant
CXAIW
$345K 0.01%
1,373,919
+574,982
+72% +$128K
ASML icon
199
ASML
ASML
$675B
$327K 0.01%
+393
New +$351K
TETE
200
DELISTED
Technology & Telecommunication Acquisition Corporation Class A Ordinary Shares
TETE
$315K 0.01%
25,837
-49,163
-66% -$593K
6 7
8
9 10

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2024 Portfolio in Review

As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company's Q3 2024 filing shows 186 new, 196 increased, 157 reduced and 179 closed positions. Its largest new stake was Eli Lilly: 130,399 shares worth $116M. The largest sale was Meta Platforms (Facebook), an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
  • Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
  • Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
  • Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
  • Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
  • Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
  • Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.